Filter
2651
Filtered Results: 2651
Text search:
Global
Drug
Facility
Featured
Recommendations
258
New Publications
868
Language
Document type
No document type
1666
Guidelines
352
Studies & Reports
349
Manuals
112
Strategic & Response Plan
91
Training Material
31
Fact sheets
26
Situation Updates
13
Resource Platforms
6
Infographics
3
Brochures
1
App
1
Countries / Regions
India
135
Kenya
98
Ethiopia
84
Global
76
Nigeria
75
Uganda
73
South Africa
71
Tanzania
62
Malawi
59
Nepal
58
Liberia
57
Zambia
50
Sierra Leone
49
Ghana
47
Western and Central Europe
40
Bangladesh
40
Myanmar / Burma
39
Rwanda
36
Africa
35
Namibia
33
Eastern Europe
28
Ukraine
27
Lesotho
25
Zimbabwe
25
Cambodia
25
Asia
25
Philippines
23
Latin America and the Carribbean
23
South–East Asia Region
17
Syria
16
Senegal
15
Burkina Faso
15
Mozambique
15
Congo, Democratic Republic of
15
Botswana
15
Indonesia
15
Russia
12
Cameroon
11
East and Southern Africa
10
Eswatini/ Swaziland
9
South Sudan
8
Pakistan
8
West and Central Africa
7
Middle East and North Africa
7
Tajikistan
6
Benin
6
Haiti
6
Colombia
5
Laos
5
Guinea
5
Venezuela
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Sudan
5
Yemen
5
Thailand
4
Mexico
4
El Salvador
4
China
4
Afghanistan
4
Germany
4
Sri Lanka
4
Peru
3
Vietnam
3
Brazil
3
Moldova
3
Palestine
3
Georgia
3
Central African Republic
3
Libya
3
Somalia
3
North Macedonia
2
Timor Leste/ East Timor
2
Chile
2
Iran
2
Albania
2
Armenia
2
USA
2
Jordan
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Papua New Guinea
2
Mali
2
Bhutan
2
Iraq
2
Madagascar
2
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Romania
1
Greece
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1205
Clinical Guidelines
237
Public Health
126
Women & Child Health
112
Key Resources
77
Capacity Building
47
Pharmacy & Technologies
36
Toolboxes
TB
337
HIV
295
AMR
156
COVID-19
125
Mental Health
95
Pharmacy
75
NTDs
60
Caregiver
55
Rapid Response
54
NCDs
40
Conflict
35
Ebola
33
Planetary Health
29
Refugee
27
Global Health Education
22
Disability
21
Health Financing Toolbox
20
Polio
14
Natural Hazards
9
Cholera
9
Specific Hazards
6
Zika
3
Social Ethics
2
To complement the Global Strategy progress reporting, this report provides a detailed look at country leadership and action toward the Every Newborn National Milestones by 2020. Countries have taken the initiative to show the way forward and have demonstrated significant progress. As part of monitor...
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
The report and an accompanying series of studies show the global uptake of the World Health Organization (WHO) Surgical Safety Checklist in its first ten years since its launch and recommend ways the Checklist can be more effectively used to improve surgical safety for millions at risk.
The report ...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra...
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
This manual was developed based on the recommendations of a global technical consultation on child health in humanitarian emergencies co-organized by WHO and UNICEF at the end of 2003. WHO in collaboration with the Centre for Refugee and Disaster Response, Bloomberg School of Public Health, Johns Ho...
India contributes to 16% of the global maternal deaths and around 27% of global newborn deaths. Reducing the burden of maternal and newborn mortality and morbidity in urban poor settings today requires an expansion of effective Maternal and Newborn Health (MNH) care services and lowering the barrier...
This FY 2017 Malaria Operational Plan presents a detailed implementation plan for Senegal, based on the strategies of PMI and the National Malaria Control Program (NMCP) strategy. It was developed in consultation with the NMCP and with the participation of national and international partners involve...
AMR is one of the Key priority of the global health security agenda action package, as well as it is one of the commitments of Ministry of Public Health Afghanistan to combat AMR. In Afghanistan because of war and some other political issues the borders of the country are not well secured and well c...
Antimicrobial resistance has become one of the most eminent threats to global health and a rising concern for healthcare specialists. All around the world, many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in high morbidity and mortality with ...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
This report is documenting the global incidence of attacks and threats against health workers, facilities, and transport around the world. The report cites 806 incidents of violence against or obstruction of health care in 43 countries and territories in ongoing wars and violent conflicts in 2020, r...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
